Illumina Inc (ILMN)

ILMN (NASDAQ:Drugs) EQUITY
$201.40
neg -3.50
-1.70%
Today's Range: 201.34 - 205.82 | ILMN Avg Daily Volume: 917,000
Last Update: 09/20/17 - 2:27 PM EDT
Volume: 651,981
YTD Performance: 60.07%
Open: $204.94
Previous Close: $204.95
52 Week Range: $127.10 - $223.24
Oustanding Shares: 146,000,000
Market Cap: 30,572,400,000
6-Month Chart
TheStreet Ratings Grade for ILMN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 10 10 9 9
Moderate Buy 1 1 1 1
Hold 5 5 4 5
Moderate Sell 0 0 0 0
Strong Sell 2 2 3 3
Mean Rec. 2.02 2.02 2.19 2.24
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 41.96
Price Earnings Comparisons:
ILMN Sector Avg. S&P 500
41.96 41.70 36.80
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
16.05% 18.37% 18.98%
GROWTH 12 Mo 3 Yr CAGR
Revenue 8.00 0.70 0.19
Net Income -6.40 2.40 0.50
EPS -1.00 2.10 0.45
Earnings for ILMN:
EBITDA 0.75B
Revenue 2.40B
Average Earnings Estimates
Qtr (09/17) Qtr (12/17) FY (12/17) FY (12/18)
Average Estimate $0.98 $1.20 $3.65 $4.41
Number of Analysts 12 10 12 12
High Estimate $1.06 $1.27 $3.70 $4.78
Low Estimate $0.92 $1.09 $3.62 $4.15
Prior Year $0.97 $0.85 $3.33 $3.65
Growth Rate (Year over Year) 1.12% 40.71% 9.53% 21.02%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
RMPIA
By

Gary Morrow

 | Aug 31, 2017 | 5:40 PM EDT
Today's breakout move in the stock is a highlight of the surging sector.
RMPIA
By

Gary Morrow

 | Aug 31, 2017 | 1:30 PM EDT
Today's breakout move in the stock is a highlight of the surging sector.
RMPIA
By

Bob Byrne

 | Aug 8, 2017 | 7:00 AM EDT
Slow markets like this demand a less-is-more approach.
RMPIA
By

Jim Cramer

 | May 8, 2017 | 6:27 AM EDT
It's a wonder to me how split this market really is.

bullishIllumina upgraded at Leerink

Mar 20, 2017 | 7:54 AM EDT
ILMN was upgraded to Outperform, Leerink Partners said. $195 price target. Estimates also increased, given higher expectations for sequencing.
By

Chris Laudani

 | Jan 12, 2017 | 9:00 AM EST
This week's introduction of the NovaSeq Series of genomic sequencers caused the stock to jump.
By

Bruce Kamich

 | Dec 13, 2016 | 12:05 PM EST
Considering the major top formation, don't get in their way.
RMPIA
By

Guy Ortmann

 | Oct 17, 2016 | 12:15 PM EDT
Technology stocks dominate the bearish ledger this week.
By

Bob Byrne

 | Oct 17, 2016 | 7:00 AM EDT
Do that if you like top ticking crowd favorites, but set a protective stop.
RMPIA
By

Brian Sozzi

 | Oct 14, 2016 | 10:00 AM EDT
If Twitter puts up a dreadful quarter, shares will sell off again.
The symmetry is holding up in MCD.  Target 1 is 163.34 if we continue to hold above h...
As far as TSLA is concerned, I still have a higher target above the market at the 409 area...
The TLT setup discussed in my last commentary is a bust. Key support was violated and it v...
BBY is getting smoked this mornings(weak forecast).  The stock is off 8% after openin...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.